Close Menu

NEW YORK — OpGen reported after the close of the market Wednesday a 17 percent increase in its third quarter revenues as it prepares for the planned merger with German diagnostics firm Curetis next year.

For the three-month period ended Sept. 30, OpGen posted revenues of $648,220 versus year-ago revenues of $552,221. Third quarter product sales rose 6 percent to $573,035 from $539,856, while the Gaithersburg, Maryland-based firm posted $75,000 in revenues from collaborations versus no such revenues in the same period last year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.